Merck (NYSE:MRK) has received a positive recommendation from EU regulators for its drug Welireg as a treatment for certain patients with von Hippel-Lindau disease, or VHL, and advanced kidney ...

Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications. Merck on Friday said the recommendations from ...

BofA Securities has recently resumed Merck & Co Inc (MRK) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on December 4, 2024, HSBC Securities had raised the ...

New funding partner Merck & Co., Inc. (NYSE: MRK) contributed $6 million, according to Ambrosia CEO Nick Traggis. The investment from Merck, based in Rahway, New Jersey, comes alongside another $3 ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other American dividend stocks. The US economy expanded by 2.8% in the third quarter of 2024 ...

Merck's KEYLYNK-001 trial showed Keytruda and Lynparza improved progression-free survival in BRCA non-mutated ovarian cancer patients. In the waveLINE-007 trial, zilovertamab vedotin with R-CHP ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best affordable stocks to buy. There has been a growing debate regarding whether the economy ...

The Series A round, was led by M Ventures (the strategic, corporate venture capital arm of Merck) and includes new investors BioProcess ... We are thrilled to lead this financing alongside our ...

giving an early look at how the BioNTech-partnered asset is shaping up against rival molecules in development at companies including Merck & Co. The DualityBio ADC is aimed at B7-H3, a target that ...